187 related articles for article (PubMed ID: 36116513)
1. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
Santos ES; Silva PC; Sousa PSA; Aquino CC; Pacheco G; Teixeira LFLS; Araujo AR; Sousa FBM; Barros RO; Ramos RM; Rocha JA; Nicolau LAD; Medeiros JVR
Chem Biol Interact; 2022 Nov; 367():110161. PubMed ID: 36116513
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
3. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
4. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
5. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
6. Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Matsoukas JM; Gadanec LK; Zulli A; Apostolopoulos V; Kelaidonis K; Ligielli I; Moschovou K; Georgiou N; Plotas P; Chasapis CT; Moore G; Ridgway H; Mavromoustakos T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885036
[TBL] [Abstract][Full Text] [Related]
7. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
8. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
[TBL] [Abstract][Full Text] [Related]
9. Could DIZE be the answer to COVID-19?
Qaradakhi T; Gadanec L; Matsoukas J; Apostolopoulos V; Zulli A
Maturitas; 2020 Oct; 140():83-84. PubMed ID: 32636103
[No Abstract] [Full Text] [Related]
10. In Silico Molecular Dynamics of Griseofulvin and Its Derivatives Revealed Potential Therapeutic Applications for COVID-19.
Aris P; Mohamadzadeh M; Wei Y; Xia X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805893
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
12. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
13. ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice.
Duan R; Xue X; Zhang QQ; Wang SY; Gong PY; E Y; Jiang T; Zhang YD
Aging (Albany NY); 2020 Jul; 12(14):14819-14829. PubMed ID: 32701063
[TBL] [Abstract][Full Text] [Related]
14. ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor.
Souza PFN; Amaral JL; Bezerra LP; Lopes FES; Freire VN; Oliveira JTA; Freitas CDT
J Biomol Struct Dyn; 2022 Aug; 40(12):5493-5506. PubMed ID: 33427102
[TBL] [Abstract][Full Text] [Related]
15. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
16. Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels.
Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Matsoukas JM; Apostolopoulos V; Burrell LM; Zulli A
Biochem Pharmacol; 2023 Feb; 208():115397. PubMed ID: 36566945
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations.
Lazniewski M; Dermawan D; Hidayat S; Muchtaridi M; Dawson WK; Plewczynski D
Methods; 2022 Jul; 203():498-510. PubMed ID: 35167916
[TBL] [Abstract][Full Text] [Related]
18. Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.
Coutinho DCO; Santos-Miranda A; Joviano-Santos JV; Foureaux G; Santos A; Rodrigues-Ferreira C; Martins-Júnior PA; Resende RR; Medei E; Vieyra A; Santos RAS; Cruz JS; Ferreira AJ
Peptides; 2022 May; 151():170746. PubMed ID: 35033621
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
20. Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Lapaillerie D; Charlier C; Guyonnet-Dupérat V; Murigneux E; Fernandes HS; Martins FG; Magalhães RP; Vieira TF; Richetta C; Subra F; Lebourgeois S; Charpentier C; Descamps D; Visseaux B; Weigel P; Favereaux A; Beauvineau C; Buron F; Teulade-Fichou MP; Routier S; Gallois-Montbrun S; Meertens L; Delelis O; Sousa SF; Parissi V
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0008322. PubMed ID: 35861550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
